Description
GDC-0349 is an ATP-competitive inhibitor of mTOR that exhibits anticancer chemotherpeutic activity. GDC-0349 displays pre-clinical efficacy in vitro and in vivo.
Product Unit Size | Cost | Quantity | Stock |
---|
GDC-0349 is an ATP-competitive inhibitor of mTOR that exhibits anticancer chemotherpeutic activity. GDC-0349 displays pre-clinical efficacy in vitro and in vivo.
Cas No. | 1207360-89-1 |
---|---|
Purity | ≥98% |
Formula | C24H32N6O3 |
Formula Wt. | 452.55 |
Chemical Name | 1-ethyl-3-[4-[4-[(3S)-3-methylmorpholin-4-yl]-7-(oxetan-3-yl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea |
IUPAC Name | 1-ethyl-3-[4-[4-[(3S)-3-methylmorpholin-4-yl]-7-(oxetan-3-yl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea |
Synonym | GDC0349 |
Solubility | DMSO 91 mg/mL (201.08 mM) Ethanol 6 mg/mL (13.25 mM) Water Insoluble |
Appearance | Tan to yellow solid |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Pei Z, Blackwood E, Liu L, et al. Discovery and Biological Profiling of Potent and Selective mTOR Inhibitor GDC-0349. ACS Med Chem Lett. 2012 Nov 29;4(1):103-7. PMID: 24900569.
Semi-synthetic vinca alkaloid found in Catharan...
BRD4 inhibitor.
β-lactam carbapenem; penicillin binding protei...
Active metabolite of losartan
Metabolite of spironolactone; Na+/K+ ATPase par...
Xanthone found in Garcinia hanburyi.
Peptide, used to tag proteins for affinity chro...
PI3K and mTOR inhibitor.
Cysteine protease inhibitor.
Iron chelator.
Sulfonylurea; ATP-sensitive K+ channel blocker....
Catalyzes hydrolysis of asparagine.
Peptide, alters uterine contractility; V1/2 and...
Aldose reductase inhibitor.
Camptothecin derivative; topoisomerase I inhibi...
2-methyl-1,4-naphthoquinone derivative
SYK/JAK inhibitor
Tetracycline; protein translation inhibitor, po...
Shellfish toxin produced by dinoflagellates and...
DNA-PK inhibitor.